An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
N/A
This observational cohort study is designed to obtain product safety inform...
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
PHASE1
The purpose of this study is to assess the effect of enzastaurin (LY317615)...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4
PHASE1
Olokizumab (OKZ) has been shown to reverse the inhibitory effect of IL-6 on...